If you are still having problems viewing this message, please click here for additional help.

Bone Marrow Transplantation
 
TABLE OF CONTENTS

Volume 53, Issue 5

In this issue
Editorial
Review Article
Article
Correspondence
Also new
AOP
 

Editorial

Introducing Prof. Shaun McCann, Bone Marrow Transplantation’s New Sommelier

Robert Peter Gale

Bone Marrow Transplantation 2018 53 :519 - 520; May 04, 2018; 10.1038/s41409-018-0129-1

 

Abstract | Full Text

Review Article

The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

Stefan O. Ciurea, Kai Cao, Marcelo Fernadez-Vina, Piyanuch Kongtim, Monzr Al Malki et al.

Bone Marrow Transplantation 2018 53 :521 - 534; January 15, 2018; 10.1038/s41409-017-0062-8

 

Abstract | Full Text

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

David Buchbinder, Debra Lynch Kelly, Rafael F. Duarte, Jeffery J. Auletta, Neel Bhatt et al.

Bone Marrow Transplantation 2018 53 :535 - 555; January 17, 2018; 10.1038/s41409-017-0055-7

 

Abstract | Full Text

Complementary therapies for fatigue after hematopoietic stem cell transplantation: an integrative review

Mohamad Baydoun & Debra L. Barton

Bone Marrow Transplantation 2018 53 :556 - 564; January 16, 2018; 10.1038/s41409-017-0073-5

 

Abstract | Full Text

Article

Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis

Barbara Deschler, Gabriele Ihorst, Susanne Schnitzler, Hartmut Bertz & Juergen Finke

Bone Marrow Transplantation 2018 53 :565 - 575; January 12, 2018; 10.1038/s41409-017-0021-4

 

Abstract | Full Text

Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients

Melhem M. Solh, Asad Bashey, Scott R. Solomon, Lawrence E. Morris, Xu Zhang et al.

Bone Marrow Transplantation 2018 53 :576 - 583; January 15, 2018; 10.1038/s41409-017-0076-2

 

Abstract | Full Text

A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation

Helge Schumacher, Sabrina Stüwe, Peter Kropp, Doreen Diedrich, Sebastian Freitag et al.

Bone Marrow Transplantation 2018 53 :584 - 590; January 15, 2018; 10.1038/s41409-017-0070-8

 

Abstract | Full Text

Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma

Massimo Eraldo Abate, Anna Paioli, Sivlia Cammelli, Marilena Cesari, Alessandra Longhi et al.

Bone Marrow Transplantation 2018 53 :591 - 599; January 15, 2018; 10.1038/s41409-017-0066-4

 

Abstract | Full Text

Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation

Ming-Rui Huo, Xu-Ying Pei, Dan Li, Ying-Jun Chang, Lan-Ping Xu et al.

Bone Marrow Transplantation 2018 53 :600 - 608; January 15, 2018; 10.1038/s41409-017-0072-6

 

Abstract | Full Text

The Japan Marrow Donor Program, 25 years of experience in achieving 20,000 bone marrow transplantations: organization structure, activity, and financial basis

Hidehiko Saito, Masaharu Ito, Shunichi Kato, Yoshihisa Kodera, Shinichiro Okamoto et al.

Bone Marrow Transplantation 2018 53 :609 - 616; January 24, 2018; 10.1038/s41409-017-0084-2

 

Abstract | Full Text

Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party

Stephen P. Robinson, Ariane Boumendil, Herve Finel, Karl S. Peggs, Patrice Chevallier et al.

Bone Marrow Transplantation 2018 53 :617 - 624; January 15, 2018; 10.1038/s41409-017-0067-3

 

Abstract | Full Text

Full-body physical therapy evaluation for pre- and post-hematopoietic cell transplant patients and the need for a modified rehabilitation musculoskeletal specific grading system for chronic graft-versus-host disease

Jaleel Mohammed, Ahmed AlGhamdi & Shahrukh K. Hashmi

Bone Marrow Transplantation 2018 53 :625 - 627; January 18, 2018; 10.1038/s41409-017-0075-3

 

Abstract | Full Text

Correspondence

Topical vitamin D analog for chronic graft versus host disease of the skin

Gregory Wallace, Kasiani C. Myers, Ashley Teusink-Cross, Stella M. Davies, Pooja Khandelwal et al.

Bone Marrow Transplantation 2018 53 :628 - 633; January 15, 2018; 10.1038/s41409-017-0031-2

 

Abstract | Full Text

Beneficial impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation: focusing on difference between stem cell sources

Takafumi Shichijo, Shigeo Fuji, Kinuko Tajima, Hiroyuki Kubo, Kenji Nozaki et al.

Bone Marrow Transplantation 2018 53 :634 - 639; January 15, 2018; 10.1038/s41409-017-0045-9

 

Abstract | Full Text

Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation

Laura K. Schmalbrock, Lynn Bonifacio, Marius Bill, Madlen Jentzsch, Karoline Schubert et al.

Bone Marrow Transplantation 2018 53 :640 - 643; January 15, 2018; 10.1038/s41409-017-0060-x

 

Abstract | Full Text

Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease

Elisabetta Calore, Antonio Marzollo, Mara Cananzi, Marco Pizzi, Massimo Rugge et al.

Bone Marrow Transplantation 2018 53 :644 - 646; January 15, 2018; 10.1038/s41409-017-0065-5

 

Abstract | Full Text

Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide

Haydar Frangoul, Misty Evans, Julie Isbell, Katie Bruce & Jennifer Domm

Bone Marrow Transplantation 2018 53 :647 - 650; January 16, 2018; 10.1038/s41409-017-0077-1

 

Abstract | Full Text

BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia

Amro Elshoury, Paul K. Wallace, Michael J. Borowitz, Angela Kader, Chris Choi et al.

Bone Marrow Transplantation 2018 53 :651 - 653; January 17, 2018; 10.1038/s41409-017-0036-x

 

Abstract | Full Text

Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma

Oscar B. Lahoud, Alison J. Moskowitz, Steven M. Horwitz, Sergio A. Giralt & Parastoo B. Dahi

Bone Marrow Transplantation 2018 53 :654 - 656; January 22, 2018; 10.1038/s41409-017-0086-0

 

Abstract | Full Text

Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway

Phoi Phoi Diep, Hans Olav Melberg, Lorentz Brinch, Jochen Buechner, Yngvar Fløisand et al.

Bone Marrow Transplantation 2018 53 :657 - 660; January 22, 2018; 10.1038/s41409-018-0091-y

 

Abstract | Full Text

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature